Medios AG | WebDisclosure

Basculer en Français

10646	Companies
226459	Keywords
154934	Articles
119869	Press releases

Home
Companies
Medios AG

PRESS RELEASE

published on 03/25/2025 at 07:50, 1 year 3 months ago

Medios expects further growth in revenue and earnings after record year 2024
Medios expects further growth in revenue and earnings after a record year in 2024. Consolidated revenue up 5.5% to €1.9 billion. EBITDA pre1 margin reaches 4.2%. Positive outlook for 2025 with revenue expected to reach €2.0 billion

Revenue Growth Earnings Forecast Record Year Medios 2025 Outlook
BRIEF

published on 03/04/2025 at 08:55, 1 year 3 months ago

Medios AG Reports Strong Earnings Growth in 2024, Eyes Further Gains in 2025

Pharmaceutical Industry Medios AG Financial Growth 2024 Results 2025 Outlook
BRIEF

published on 03/04/2025 at 08:55, 1 year 3 months ago

Medios AG annonce une forte croissance de ses bénéfices en 2024 et prévoit de nouveaux gains en 2025

Croissance Financière Medios AG Résultats 2024 Industrie Pharmaceutique Perspectives 2025
PRESS RELEASE

published on 03/04/2025 at 08:50, 1 year 3 months ago

Preliminary figures for Medios AG 2024: Significant increase in earnings and margins – positive outlook for 2025
Medios AG reports significant increase in earnings and margins for 2024, positive outlook for 2025. Preliminary figures show revenue reaching €1.9 billion and EBITDA pre1 around €79 million

Revenue Outlook Earnings Medios AG Margins
BRIEF

published on 12/12/2024 at 13:32, 1 year 6 months ago

Medios AG Adjusts Full-Year Financial Forecast

Revenue Increase EBITDA Margin Financial Forecast Medios AG Specialty Pharma
BRIEF

published on 12/12/2024 at 13:32, 1 year 6 months ago

Medios AG ajuste ses prévisions financières pour l'ensemble de l'année

Medios AG Prévisions Financières Marge D'EBITDA Augmentation Des Revenus Spécialité Pharmaceutique
PRESS RELEASE

published on 12/12/2024 at 13:27, 1 year 6 months ago

EQS-Adhoc: Medios AG: Specification of the full-year forecast
Medios AG specifies full-year forecast: revenues expected to be c. €1.85 billion & EBITDA pre1 of c. €80 million, with an EBITDA pre1 margin around 4.3%

Revenues Medios AG Margin Full-year Forecast EBITDA Pre1
BRIEF

published on 11/12/2024 at 08:46, 1 year 7 months ago

Medios AG Achieves Record Third Quarter in 2024

Medios AG Earnings Growth Financial Outlook Q3 2024 Specialty Pharma
BRIEF

published on 11/12/2024 at 08:46, 1 year 7 months ago

Medios AG réalise un troisième trimestre record en 2024

Medios AG Perspectives Financières Croissance Des Bénéfices 3e Trimestre 2024 Spécialité Pharmaceutique
PRESS RELEASE

published on 11/12/2024 at 08:41, 1 year 7 months ago

Medios AG reports record quarter Q3 2024 with significant increase in earnings and margins
Medios AG reports record quarter Q3 2024 with significant increase in earnings and margins. EBITDA pre1 reaches €24.6 million (+42.9%) and revenue in the nine-month period up 4.2%

Revenue Growth Medios AG Earnings Increase EBITDA Pre1 Record Quarter

Accesswire

Published on 06/26/2026 at 15:05, 23 minutes ago

Vox Royalty Sells I-80 Gold Offtake Stream
Published on 06/26/2026 at 14:05, 1 hour 23 minutes ago

SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 1 hour 28 minutes ago

Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 2 hours 28 minutes ago

Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 2 hours 43 minutes ago

Northern Dynasty Reports Oral Arguments Held

View all ACCESSWIRE

EQS Group

Published on 06/26/2026 at 15:18, 9 minutes ago

Form 8.3 - The Vanguard Group, Inc.: IP Group plc
Published on 06/26/2026 at 15:17, 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 06/26/2026 at 15:17, 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Published on 06/26/2026 at 15:16, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Gamma Communications plc
Published on 06/26/2026 at 15:15, 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: easyJet plc

Les Echos

Published on 06/26/2026 at 14:44, 43 minutes ago

Safran information
Published on 06/26/2026 at 14:44, 43 minutes ago

Information Safran
Published on 06/26/2026 at 12:16, 3 hours 11 minutes ago

Rapport semestriel SIEHM au 30 avril 2026
Published on 06/26/2026 at 07:00, 8 hours 28 minutes ago

Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 8 hours 28 minutes ago

Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel

View all LES ECHOS COMFI WIRE